Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Processa Pharmaceuticals, Inc. (PCSA) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Processa Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1533743.
Total stock buying since 2020: $682,367.
Total stock sales since 2020: $5,361,591.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 267,600 | $213,544 | 0 | $0 | 61,295 | $0 |
| 2024 | 42,000 | $108,569 | 0 | $0 | 19,970 | $0 |
| 2023 | 80,000 | $40,000 | 0 | $0 | 100,770 | $0 |
| 2022 | 4,000 | $9,777 | 1,854 | $6,118 | 48,916 | $0 |
| 2021 | 21,500 | $111,052 | 502,600 | $5,355,473 | 12,500 | $0 |
| 2020 | 67,250 | $199,425 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-04 | 0 | $0 | 0 | $0 | 61,295 | $0 |
| 2025-01 | 267,600 | $213,544 | 0 | $0 | 0 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 3,220 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 8,375 | $0 |
| 2024-02 | 21,500 | $54,100 | 0 | $0 | 0 | $0 |
| 2024-01 | 20,500 | $54,469 | 0 | $0 | 8,375 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 100,770 | $0 |
| 2023-04 | 80,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 36,416 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2022-05 | 2,000 | $3,190 | 0 | $0 | 0 | $0 |
| 2022-04 | 2,000 | $6,587 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 1,854 | $6,118 | 0 | $0 |
| 2021-12 | 12,500 | $52,796 | 9,700 | $46,380 | 0 | $0 |
| 2021-10 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2021-08 | 4,000 | $24,088 | 0 | $0 | 0 | $0 |
| 2021-06 | 5,000 | $34,168 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 463,971 | $4,976,804 | 0 | $0 |
| 2021-02 | 0 | $0 | 28,929 | $332,289 | 0 | $0 |
| 2020-10 | 67,250 | $199,425 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | Bigora Sian (Chief Development Officer) | Option Ex | 15,059 | .00 | 0 |
| 2025-04-01 | Lin Patrick (Chief Business - Strategy Officer) | Option Ex | 14,482 | .00 | 0 |
| 2025-04-01 | Guy Wendy (Chief Administrative Officer) | Option Ex | 14,482 | .00 | 0 |
| 2025-04-01 | Young David (Pres. Research & Development) | Option Ex | 17,272 | .00 | 0 |
| 2025-01-27 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 43,500 | .80 | 34,713 |
| 2025-01-27 | Ng George K (Chief Executive Officer) | Buy | 87,200 | .80 | 69,585 |
| 2025-01-27 | Young David (Pres. Research & Development) | Buy | 124,500 | .80 | 99,351 |
| 2025-01-27 | Yorke Justin W | Buy | 12,400 | .80 | 9,895 |
| 2024-07-10 | Bigora Sian (Chief Development Officer) | Option Ex | 644 | .00 | 0 |
| 2024-07-10 | Lin Patrick (Chief Business - Strategy Officer) | Option Ex | 644 | .00 | 0 |
| 2024-07-10 | Guy Wendy (Chief Administrative Officer) | Option Ex | 644 | .00 | 0 |
| 2024-07-10 | Stanker James H (Chief Financial Officer) | Option Ex | 644 | .00 | 0 |
| 2024-07-10 | Young David (Pres. Research & Development) | Option Ex | 644 | .00 | 0 |
| 2024-04-05 | Bigora Sian (Chief Development Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-04-05 | Lin Patrick (Chief Business - Strategy Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-04-05 | Guy Wendy (Chief Administrative Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-04-05 | Stanker James H (Chief Financial Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-04-05 | Young David (Pres. Research & Development) | Option Ex | 1,675 | .00 | 0 |
| 2024-02-06 | Young David (Pres. Research & Development) | Buy | 20,000 | 2.52 | 50,500 |
| 2024-02-01 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 1,500 | 2.40 | 3,600 |
| 2024-01-31 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 2,500 | 2.37 | 5,925 |
| 2024-01-30 | Ng George K (Chief Executive Officer) | Buy | 10,000 | 2.70 | 27,000 |
| 2024-01-30 | Yorke Justin W | Buy | 8,000 | 2.69 | 21,544 |
| 2024-01-01 | Bigora Sian (Chief Development Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | Lin Patrick (Chief Business - Strategy Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | Guy Wendy (Chief Administrative Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | Stanker James H (Chief Financial Officer) | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | Young David (Pres. Research & Development) | Option Ex | 1,675 | .00 | 0 |
| 2023-06-27 | Pannu Geraldine | Option Ex | 23,636 | .00 | 0 |
| 2023-06-27 | Baluch Khoso | Option Ex | 15,455 | .00 | 0 |
| 2023-06-27 | Neal James R | Option Ex | 14,407 | .00 | 0 |
| 2023-06-27 | Yorke Justin W | Option Ex | 23,636 | .00 | 0 |
| 2023-06-27 | Thompson Virgil | Option Ex | 23,636 | .00 | 0 |
| 2023-04-14 | Young David (President & CEO) | Buy | 20,000 | .55 | 11,000 |
| 2023-04-13 | Young David (President & CEO) | Buy | 20,000 | .48 | 9,600 |
| 2023-04-12 | Young David (President & CEO) | Buy | 20,000 | .45 | 9,000 |
| 2023-04-11 | Young David (President & CEO) | Buy | 20,000 | .52 | 10,400 |
| 2022-12-31 | Pannu Geraldine | Option Ex | 18,208 | .00 | 0 |
| 2022-12-31 | Thompson Virgil | Option Ex | 18,208 | .00 | 0 |
| 2022-10-06 | Floyd Robert Michael (Chief Operating Officer) | Option Ex | 12,500 | .00 | 0 |
| 2022-05-17 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 2,000 | 1.59 | 3,190 |
| 2022-04-07 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 800 | 3.54 | 2,835 |
| 2022-04-06 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 1,200 | 3.13 | 3,752 |
| 2022-01-27 | Yorke Justin W | Sale | 1,854 | 3.30 | 6,118 |
| 2021-12-14 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 6,000 | 4.00 | 24,000 |
| 2021-12-06 | Yorke Justin W | Sale | 4,200 | 4.71 | 19,782 |
| 2021-12-03 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 3,500 | 4.80 | 16,796 |
| 2021-12-03 | Yorke Justin W | Sale | 5,500 | 4.84 | 26,598 |
| 2021-10-06 | Floyd Robert Michael (Chief Operating Officer) | Option Ex | 12,500 | .00 | 0 |
| 2021-08-26 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 4,000 | 6.02 | 24,088 |
| 2021-06-22 | Floyd Robert Michael (Chief Operating Officer) | Buy | 2,000 | 7.03 | 14,058 |
| 2021-06-21 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 2,000 | 6.65 | 13,300 |
| 2021-06-21 | Stanker James H (Chief Financial Officer) | Buy | 1,000 | 6.81 | 6,810 |
| 2021-04-14 | Yorke Justin W | Sale | 9,700 | 9.42 | 91,374 |
| 2021-04-13 | Yorke Justin W | Sale | 6,500 | 9.86 | 64,089 |
| 2021-04-08 | Besser James E | Sale | 400,000 | 10.76 | 4,304,000 |
| 2021-04-07 | Besser James E | Sale | 16,000 | 10.67 | 170,720 |
| 2021-04-06 | Besser James E | Sale | 31,771 | 10.91 | 346,621 |
| 2021-02-22 | Besser James E | Sale | 20,929 | 11.56 | 241,939 |
| 2021-02-19 | Besser James E | Sale | 3,000 | 11.20 | 33,600 |
| 2021-02-18 | Besser James E | Sale | 5,000 | 11.35 | 56,750 |
| 2020-10-02 | Besser James E | Buy | 30,000 | 4.04 | 121,200 |
| 2020-10-01 | Lin Patrick (Chief Business - Strategy Officer) | Buy | 31,250 | 2.10 | 65,625 |
| 2020-10-01 | Stanker James H (Chief Financial Officer) | Buy | 6,000 | 2.10 | 12,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of PCSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Processa Pharmaceuticals, Inc. (symbol PCSA, CIK number 1533743) see the Securities and Exchange Commission (SEC) website.